• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jeffrey Gudin: PDMPs Are Getting Better, but Still Room for Improvement

Video

There are 2 ways prescription drug monitoring programs can improve, said Jeffrey Gudin, MD, Pain Management and Palliative Care at Englewood Hospital and Medical Center.

There are 2 ways prescription drug monitoring programs can improve, said Jeffrey Gudin, MD, Pain Management and Palliative Care at Englewood Hospital and Medical Center.

Transcript

How can prescription drug monitoring programs be improved?

So the prescription drug monitoring programs have been getting better every year. We started out with a relatively archaic system which only screened one state and that has morphed into a fully electronic database that you can screen multiple states. I’d say there’s 2 ways that we can make our prescription drug monitoring programs better. One, have it become national, and I know there’s some push to get that done so we can screen patients who snowbird in Arizona or North Carolina or Florida, when they’re living in New York or New Jersey. And the other way is to include all medications in the prescription drug monitoring program. Now that sounds like a big task, but there are some of the electronic record systems that already do it and are able to scan the national pharmacy databases and give you an idea of the medications that your patients take, because we have drug-drug interactions that happen not just with controlled substances but also with everyday medicines as well. I think those are ways we can improve the program.

Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
ASCO GI 2026 Recap
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Dr Marco del Riccio
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Dr Debra Patt
Dr Marco del Riccio
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
© 2026 MJH Life Sciences
AJMC®
All rights reserved.